Stage
Grant | AliveAbout CureImmune
CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.
CureImmune Headquarter Location
Fitzsimmons Bioscience Center 12635 E. Montview Blvd. Suite 100G
Aurora, Colorado, 80045,
United States
Expert Collections containing CureImmune
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CureImmune is included in 1 Expert Collection, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Where is CureImmune's headquarters?
CureImmune's headquarters is located at Fitzsimmons Bioscience Center, Aurora.
What is CureImmune's latest funding round?
CureImmune's latest funding round is Grant.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.